78 related articles for article (PubMed ID: 8037710)
1. TPA-induced differentiation of human rhabdomyosarcoma cells involves dephosphorylation and nuclear accumulation of mutant P53.
Germani A; Fusco C; Martinotti S; Musarò A; Molinaro M; Zani BM
Biochem Biophys Res Commun; 1994 Jul; 202(1):17-24. PubMed ID: 8037710
[TBL] [Abstract][Full Text] [Related]
2. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.
Perego P; Giarola M; Righetti SC; Supino R; Caserini C; Delia D; Pierotti MA; Miyashita T; Reed JC; Zunino F
Cancer Res; 1996 Feb; 56(3):556-62. PubMed ID: 8564971
[TBL] [Abstract][Full Text] [Related]
3. Mutant human tumor suppressor p53 modulates the activation of mitogen-activated protein kinase and nuclear factor-kappaB, but not c-Jun N-terminal kinase and activated protein-1.
Gulati AP; Yang YM; Harter D; Mukhopadhyay A; Aggarwal BB; Benzil DL; Whysner J; Albino AP; Murali R; Jhanwar-Uniyal M
Mol Carcinog; 2006 Jan; 45(1):26-37. PubMed ID: 16267831
[TBL] [Abstract][Full Text] [Related]
4. Different p53 mutations produce distinct effects on the ability of colon carcinoma cells to become blocked at the G1/S boundary after irradiation.
Pocard M; Chevillard S; Villaudy J; Poupon MF; Dutrillaux B; Remvikos Y
Oncogene; 1996 Feb; 12(4):875-82. PubMed ID: 8632910
[TBL] [Abstract][Full Text] [Related]
5. p53 mutational status and survival of human breast cancer MCF-7 cell variants after exposure to X rays or fission neutrons.
Balcer-Kubiczek EK; Yin J; Lin K; Harrison GH; Abraham JM; Meltzer SJ
Radiat Res; 1995 Jun; 142(3):256-62. PubMed ID: 7761574
[TBL] [Abstract][Full Text] [Related]
6. p21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells.
Ciccarelli C; Marampon F; Scoglio A; Mauro A; Giacinti C; De Cesaris P; Zani BM
Mol Cancer; 2005 Dec; 4():41. PubMed ID: 16351709
[TBL] [Abstract][Full Text] [Related]
7. Expression of memory, differentiation, and repression of c-myc and p53 genes in human RD/TE-671 cells induced by a ureido-derivative of pyridine (UDP-4).
Pappas IS; Sophianos D; Tzartos S; Tsiftsoglou AS
Cell Growth Differ; 1996 Jun; 7(6):797-809. PubMed ID: 8780893
[TBL] [Abstract][Full Text] [Related]
8. p53-mediated transcriptional activity increases in differentiating epidermal keratinocytes in association with decreased p53 protein.
Weinberg WC; Azzoli CG; Chapman K; Levine AJ; Yuspa SH
Oncogene; 1995 Jun; 10(12):2271-9. PubMed ID: 7784075
[TBL] [Abstract][Full Text] [Related]
9. Mutations in p53 are frequent in the preneoplastic stage of mouse mammary tumor development.
Jerry DJ; Ozbun MA; Kittrell FS; Lane DP; Medina D; Butel JS
Cancer Res; 1993 Jul; 53(14):3374-81. PubMed ID: 8324748
[TBL] [Abstract][Full Text] [Related]
10. Phorbol esters attenuate the expression of p53 in cells treated with doxorubicin and protect TS-P53/K562 from apoptosis.
Magnelli L; Cinelli M; Chiarugi V
Biochem Biophys Res Commun; 1995 Oct; 215(2):641-5. PubMed ID: 7488003
[TBL] [Abstract][Full Text] [Related]
11. Induction of apoptosis in human choriocarcinoma cell lines by treatment with 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-quinolinone (vesnarinone).
Isaka K; Fujito A; Sagawa Y; Yudate T; Nishi H; Ito H; Takayama M
Oncol Rep; 2002; 9(6):1299-305. PubMed ID: 12375038
[TBL] [Abstract][Full Text] [Related]
12. p53 alterations in chemically induced hamster cheek-pouch lesions.
Gimenez-Conti IB; LaBate M; Liu F; Osterndorff E
Mol Carcinog; 1996 Aug; 16(4):197-202. PubMed ID: 8784462
[TBL] [Abstract][Full Text] [Related]
13. Induction of apoptosis in breast cancer cells by TPA.
Li Y; Bhuiyan M; Mohammad RM; Sarkar FH
Oncogene; 1998 Dec; 17(22):2915-20. PubMed ID: 9879997
[TBL] [Abstract][Full Text] [Related]
14. [Effects of exogenous wild type p53 on malignant growth of human lung cancer cell line].
Wang H; Lai B; Li J
Zhonghua Jie He He Hu Xi Za Zhi; 1998 May; 21(5):268-72. PubMed ID: 11326947
[TBL] [Abstract][Full Text] [Related]
15. The human tumour suppressor gene p53 is alternatively spliced in normal cells.
Flaman JM; Waridel F; Estreicher A; Vannier A; Limacher JM; Gilbert D; Iggo R; Frebourg T
Oncogene; 1996 Feb; 12(4):813-8. PubMed ID: 8632903
[TBL] [Abstract][Full Text] [Related]
16. 12-O-tetradecanoylphorbol-13-acetate-induced differentiation of a human rhabdomyosarcoma cell line.
Aguanno S; Bouchè M; Adamo S; Molinaro M
Cancer Res; 1990 Jun; 50(11):3377-82. PubMed ID: 2159381
[TBL] [Abstract][Full Text] [Related]
17. Cell cycle-dependent regulation of nuclear p53 traffic occurs in one subclass of human tumor cells and in untransformed cells.
David-Pfeuty T; Chakrani F; Ory K; Nouvian-Dooghe Y
Cell Growth Differ; 1996 Sep; 7(9):1211-25. PubMed ID: 8877102
[TBL] [Abstract][Full Text] [Related]
18. The MDM2 oncoprotein is overexpressed in rhabdomyosarcoma cell lines and stabilizes wild-type p53 protein.
Keleti J; Quezado MM; Abaza MM; Raffeld M; Tsokos M
Am J Pathol; 1996 Jul; 149(1):143-51. PubMed ID: 8686737
[TBL] [Abstract][Full Text] [Related]
19. Comparative assessment of the functional p53 status in glioma cells.
Kim EL; Yoshizato K; Kluwe L; Meissner H; Warnecke G; Zapf S; Westphal M; Deppert W; Giese A
Anticancer Res; 2005; 25(1A):213-24. PubMed ID: 15816541
[TBL] [Abstract][Full Text] [Related]
20. 12-O-tetradecanoylphorbol-13-acetate and staurosporine induce increased retinoblastoma tumor suppressor gene expression with megakaryocytic differentiation of leukemic cells.
Yen A; Varvayanis S; Platko JD
Cancer Res; 1993 Jul; 53(13):3085-91. PubMed ID: 8363661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
